WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities
Rhea-AI Summary
WuXi AppTec (WUXAY) has completed significant share repurchase and acquisition activities in Q2 2025. The company executed an RMB1.0 billion A-share repurchase program, buying back 15,775,377 A-shares at RMB63.39 per share (0.55% of total shares) between April 18 and June 20, 2025, which were subsequently cancelled on June 24.
Additionally, the company acquired HKD2.5 billion worth of H-shares (34,092,975 shares, 1.19% of total shares) through its 2025 H Share Award and Trust Scheme. The H-share acquisition is tied to revenue targets, with HKD1.5 billion in shares to be granted if 2025 revenue reaches RMB42.0 billion, and an additional HKD1.0 billion if revenue hits RMB43.0 billion.
Positive
- Completed RMB1.0 billion A-share repurchase program to enhance shareholder value
- Acquired HKD2.5 billion worth of H-shares for employee retention without diluting existing shareholders
- H-share awards are performance-linked to ambitious revenue targets of RMB42-43 billion for 2025
Negative
- Significant cash outlay of approximately RMB3.1 billion total for share programs
- Share acquisitions represent relatively small percentage of total shares (combined 1.74%)
News Market Reaction
On the day this news was published, WUXAY declined 1.76%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
The Company repurchased and cancelled
Here is a full update on both programs:
Update on A-Share Repurchase and Cancellation:
- On April 8, 2025, the Company's Board of Directors approved an
RMB1.0 billion A-share repurchase and cancellation program. It took this action to uphold the Company's value and protect the interests of shareholders. - From April 18, 2025 to June 20, 2025, WuXi AppTec spent
RMB1.0 billion (exclusive of transaction fees) to buy an aggregate of 15,775,377 A Shares (representing approximately0.55% of the Company's total issued share capital as of June 23, 2025) at an average price ofRMB63.39 per share. - On June 24, 2025, WuXi AppTec completed cancellation of all A Shares repurchased under this program.
- For more information, please refer to the Company's relevant announcement:
Update on H-Share Acquisition:
- As of June 27, 2025, the Company instructed the Scheme Trustee to complete the acquisition of
HKD2.5 billion worth of H Shares through on-market transactions for the purpose of the 2025 H Share Award and Trust Scheme, with an aggregate of 34,092,975 H shares acquired (representing approximately1.19% of the Company's total issued share capital as of June 30, 2025), and will not result in dilution to existing shareholders. - These acquired H shares will be used to continuously attract and retain top talents, strengthen the collective capabilities of management team, and enhance the resilience of the Company's business operations and management.
- According to the 2025 H Share Award and Trust Scheme:
- No more than
HKD1.5 billion worth of H shares will be granted to the selected employees upon the Company's 2025 revenue achieving at leastRMB42.0 billion . - An additional
HKD1.0 billion worth of H shares (and thus a total ofHKD2.5 billion worth of H shares) will be granted to the selected employees upon the Company's 2025 revenue achieving at leastRMB43.0 billion .
- No more than
- For more information, please refer to the Company's relevant announcements:
- June 13, 2025: Completion of the acquisition of H shares by the Scheme Trustee in the amount of
HK under the basic condition of grant of the 2025 H Share Award and Trust Scheme.$1.5 billion - June 30, 2025: Completion of the acquisition of H shares by the Scheme Trustee in the amount of
HK under the additional condition of grant of the 2025 H Share Award and Trust Scheme.$1 billion
- June 13, 2025: Completion of the acquisition of H shares by the Scheme Trustee in the amount of
About WuXi AppTec
WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across
View original content:https://www.prnewswire.com/news-releases/wuxi-apptec-provides-updates-on-q2-share-repurchaseacquisition-activities-302499523.html
SOURCE WuXi AppTec